CFAP97D1
gene geneOn this page
Summary
CFAP97D1 (CFAP97 domain containing 1, HGNC:37241) is a protein-coding gene on chromosome 17q21.31, encoding Sperm axonemal maintenance protein CFAP97D1 (B2RV13). Required for male fertility through its role in axonemal doublet stabilization which is essential for sperm motility and fertilization.
Predicted to be involved in sperm axoneme assembly.
Source: NCBI Gene 284067 — RefSeq curated summary.
At a glance
- GWAS associations: 14
- Clinical variants (ClinVar): 1 total
- MANE Select transcript:
NM_001136483
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:37241 |
| Approved symbol | CFAP97D1 |
| Name | CFAP97 domain containing 1 |
| Location | 17q21.31 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000231256 |
| Ensembl biotype | protein_coding |
| OMIM | 619866 |
| Entrez | 284067 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 1 protein_coding, 1 nonsense_mediated_decay
ENST00000449302, ENST00000590148
RefSeq mRNA: 2 — MANE Select: NM_001136483
NM_001136483, NM_001353400
CCDS: CCDS45695
Canonical transcript exons
ENST00000449302 — 6 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001602401 | 43783837 | 43783893 |
| ENSE00001642719 | 43781119 | 43781189 |
| ENSE00001661757 | 43783180 | 43783303 |
| ENSE00001790760 | 43780435 | 43780586 |
| ENSE00001805809 | 43781774 | 43781892 |
| ENSE00002777027 | 43784383 | 43787620 |
Expression profiles
Bgee: expression breadth broad, 43 present calls, max score 95.08.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.1014 / max 81.1953, expressed in 4 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 161089 | 0.1014 | 4 |
Top tissues by expression
193 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| sperm | CL:0000019 | 95.08 | gold quality |
| right testis | UBERON:0004534 | 91.98 | gold quality |
| left testis | UBERON:0004533 | 91.86 | gold quality |
| testis | UBERON:0000473 | 87.95 | gold quality |
| adult organism | UBERON:0007023 | 77.78 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 74.85 | gold quality |
| sural nerve | UBERON:0015488 | 58.63 | silver quality |
| lower lobe of lung | UBERON:0008949 | 54.57 | silver quality |
| cardiac muscle of right atrium | UBERON:0003379 | 54.34 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 54.23 | gold quality |
| kidney epithelium | UBERON:0004819 | 53.93 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 53.60 | gold quality |
| upper arm skin | UBERON:0004263 | 53.52 | gold quality |
| pancreatic ductal cell | CL:0002079 | 51.37 | silver quality |
| myocardium | UBERON:0002349 | 50.25 | gold quality |
| ileal mucosa | UBERON:0000331 | 49.89 | silver quality |
| tibialis anterior | UBERON:0001385 | 49.06 | silver quality |
| deltoid | UBERON:0001476 | 48.08 | gold quality |
| leukocyte | CL:0000738 | 47.42 | silver quality |
| monocyte | CL:0000576 | 47.36 | silver quality |
| nasal cavity epithelium | UBERON:0005384 | 47.03 | gold quality |
| cortical plate | UBERON:0005343 | 46.66 | gold quality |
| quadriceps femoris | UBERON:0001377 | 46.41 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 45.53 | silver quality |
| vastus lateralis | UBERON:0001379 | 45.50 | gold quality |
| prefrontal cortex | UBERON:0000451 | 45.13 | gold quality |
| layer of synovial tissue | UBERON:0007616 | 43.55 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 43.37 | gold quality |
| cauda epididymis | UBERON:0004360 | 43.12 | gold quality |
| secondary oocyte | CL:0000655 | 42.57 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 3.90 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
16 targeting CFAP97D1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-7110-3P | 100.00 | 73.18 | 2486 |
| HSA-MIR-6873-3P | 100.00 | 71.42 | 2626 |
| HSA-MIR-6833-3P | 100.00 | 70.63 | 3197 |
| HSA-MIR-4768-5P | 100.00 | 69.49 | 2861 |
| HSA-MIR-627-3P | 99.90 | 71.42 | 3316 |
| HSA-MIR-5582-3P | 99.86 | 72.48 | 4221 |
| HSA-MIR-4307 | 99.82 | 70.45 | 3374 |
| HSA-MIR-6817-3P | 99.79 | 68.35 | 2126 |
| HSA-MIR-567 | 99.63 | 68.57 | 1219 |
| HSA-MIR-4711-3P | 98.97 | 66.87 | 1020 |
| HSA-MIR-3189-5P | 97.55 | 66.71 | 655 |
| HSA-MIR-3157-5P | 97.41 | 67.61 | 998 |
| HSA-MIR-5699-5P | 97.36 | 67.03 | 1014 |
| HSA-MIR-643 | 97.35 | 67.91 | 805 |
| HSA-MIR-103B | 95.51 | 66.85 | 441 |
| HSA-MIR-4323 | 93.93 | 63.89 | 656 |
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Cfap97d1 | ENSMUSG00000010841 |
| rattus_norvegicus | Cfap97d1 | ENSRNOG00000036796 |
Protein
Protein identifiers
Sperm axonemal maintenance protein CFAP97D1 — B2RV13 (reviewed: B2RV13)
Alternative names: CFAP97 domain-containing protein 1
All UniProt accessions (2): B2RV13, K7ER76
UniProt curated annotations — full annotation on UniProt →
Function. Required for male fertility through its role in axonemal doublet stabilization which is essential for sperm motility and fertilization.
Tissue specificity. Expressed exclusively in testis.
Similarity. Belongs to the CFAP97 family.
RefSeq proteins (2): NP_001129955, NP_001340329 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR029488 | Hmw/CFAP97 | Family |
| IPR038792 | CFAP97D1/2 | Family |
Pfam: PF13879
UniProt features (2 total): chain 1, coiled-coil region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-B2RV13-F1 | 84.80 | 0.49 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 42 (showing top):
GOBP_MALE_GAMETE_GENERATION, GOBP_CILIUM_ORGANIZATION, GOBP_CILIUM_MOVEMENT, GOBP_CILIUM_OR_FLAGELLUM_DEPENDENT_CELL_MOTILITY, GOBP_ORGANELLE_ASSEMBLY, GOBP_CELLULAR_PROCESS_INVOLVED_IN_REPRODUCTION_IN_MULTICELLULAR_ORGANISM, GOBP_MICROTUBULE_BUNDLE_FORMATION, GOBP_DEVELOPMENTAL_PROCESS_INVOLVED_IN_REPRODUCTION, GOBP_MOTILE_CILIUM_ASSEMBLY, GOBP_CELL_PROJECTION_ORGANIZATION, GOBP_AXONEME_ASSEMBLY, GOBP_MICROTUBULE_CYTOSKELETON_ORGANIZATION, ZNF664_TARGET_GENES, MIR627_3P, MIR4307
GO Biological Process (1): sperm axoneme assembly (GO:0007288)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (0):
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| developmental process involved in reproduction | 1 |
| axoneme assembly | 1 |
| sperm flagellum assembly | 1 |
| binding | 1 |
Protein interactions and networks
STRING
1234 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| CFAP97D1 | C17orf50 | Q8WW18 | 691 |
| CFAP97D1 | C5orf52 | A6NGY3 | 610 |
| CFAP97D1 | SPMAP1 | A8MV24 | 582 |
| CFAP97D1 | SPEM2 | Q0P670 | 580 |
| CFAP97D1 | AXDND1 | Q5T1B0 | 543 |
| CFAP97D1 | ENTPD6 | O75354 | 542 |
| CFAP97D1 | MRPL34 | Q9BQ48 | 531 |
| CFAP97D1 | TMEM42 | Q69YG0 | 512 |
| CFAP97D1 | CCDC24 | Q8N4L8 | 478 |
| CFAP97D1 | TLCD5 | Q6ZRR5 | 475 |
| CFAP97D1 | SPMIP9 | Q96LM6 | 474 |
| CFAP97D1 | CCDC116 | Q8IYX3 | 447 |
| CFAP97D1 | KRTAP9-7 | A8MTY7 | 446 |
| CFAP97D1 | TBC1D3K | A0A087X1G2 | 446 |
| CFAP97D1 | FBXW12 | Q6X9E4 | 439 |
IntAct
6 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| CFAP97D1 | BCL6 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CFAP97D1 | PPIB | psi-mi:“MI:0915”(physical association) | 0.400 |
| CFAP97D1 | TPM2 | psi-mi:“MI:0914”(association) | 0.350 |
| BCL6 | CFAP97D1 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (13): CST6 (Affinity Capture-MS), ACADVL (Affinity Capture-MS), CALML3 (Affinity Capture-MS), S100A2 (Affinity Capture-MS), TPM2 (Affinity Capture-MS), CALML3 (Affinity Capture-MS), S100A2 (Affinity Capture-MS), CST6 (Affinity Capture-MS), C17orf105 (Two-hybrid), PPIB (Proximity Label-MS), C17orf105 (Negative Genetic), NOLC1 (Cross-Linking-MS (XL-MS)), C17orf105 (Protein-peptide)
ESM2 similar proteins: A0A1B0GU71, A6QPI4, B2RV13, D4A6L0, E1BBQ2, F1LQY6, G3UW36, O08856, P15382, P53801, P55199, P56182, Q08CB3, Q0VF94, Q148E1, Q17RQ9, Q2KJ58, Q32Q90, Q4R5F9, Q4V8A6, Q4VA36, Q5I0I4, Q5NVI6, Q5R8Q2, Q5T6X4, Q5T848, Q5XII8, Q68EN5, Q6P767, Q8C419, Q8CHT6, Q8R143, Q8R1T1, Q8TBN0, Q8VDV3, Q8WUX9, Q90YH8, Q91WM6, Q91ZP9, Q96IL0
Diamond homologs: A0A1B0GU71, B2RV13, G3UW36, Q9DAN9
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
1 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 1 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
782 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 17:43781890:G:GT | donor_gain | 1.0000 |
| 17:43781890:GAG:G | donor_gain | 1.0000 |
| 17:43781892:GGTAA:G | donor_loss | 1.0000 |
| 17:43781893:GTAAT:G | donor_loss | 1.0000 |
| 17:43781894:T:A | donor_loss | 1.0000 |
| 17:43784371:A:AG | acceptor_gain | 1.0000 |
| 17:43784371:ACT:A | acceptor_gain | 1.0000 |
| 17:43784372:C:G | acceptor_gain | 1.0000 |
| 17:43784373:T:A | acceptor_gain | 1.0000 |
| 17:43784381:A:G | acceptor_gain | 1.0000 |
| 17:43780551:GCCAC:G | donor_gain | 0.9900 |
| 17:43780583:ATAG:A | donor_loss | 0.9900 |
| 17:43780587:GT:G | donor_loss | 0.9900 |
| 17:43781772:A:AG | acceptor_gain | 0.9900 |
| 17:43781772:AG:A | acceptor_gain | 0.9900 |
| 17:43781773:G:GG | acceptor_gain | 0.9900 |
| 17:43781773:GG:G | acceptor_gain | 0.9900 |
| 17:43781773:GGGT:G | acceptor_gain | 0.9900 |
| 17:43781893:G:GG | donor_gain | 0.9900 |
| 17:43783835:A:G | acceptor_gain | 0.9900 |
| 17:43784380:A:AG | acceptor_gain | 0.9900 |
| 17:43784380:AAG:A | acceptor_gain | 0.9900 |
| 17:43780555:C:CG | donor_gain | 0.9800 |
| 17:43780582:AATAG:A | donor_gain | 0.9800 |
| 17:43781770:CCAG:C | acceptor_loss | 0.9800 |
| 17:43781771:CAG:C | acceptor_loss | 0.9800 |
| 17:43781862:T:TA | donor_gain | 0.9800 |
| 17:43781863:G:GA | donor_gain | 0.9800 |
| 17:43783301:C:T | donor_gain | 0.9800 |
| 17:43783759:A:G | acceptor_gain | 0.9800 |
AlphaMissense
1094 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 17:43781820:T:C | L81P | 0.958 |
| 17:43783840:T:C | S148P | 0.956 |
| 17:43783203:G:C | R113P | 0.946 |
| 17:43781834:G:C | A86P | 0.945 |
| 17:43783231:C:A | N122K | 0.927 |
| 17:43783231:C:G | N122K | 0.927 |
| 17:43783229:A:G | N122D | 0.925 |
| 17:43783242:T:C | L126P | 0.923 |
| 17:43781812:C:A | N78K | 0.920 |
| 17:43781812:C:G | N78K | 0.920 |
| 17:43783233:A:C | Q123P | 0.920 |
| 17:43781840:G:C | A88P | 0.915 |
| 17:43783251:T:C | L129P | 0.915 |
| 17:43783209:T:C | L115P | 0.910 |
| 17:43781131:T:A | V46D | 0.902 |
| 17:43781866:T:A | D96E | 0.892 |
| 17:43781866:T:G | D96E | 0.892 |
| 17:43783298:T:A | W145R | 0.886 |
| 17:43783298:T:C | W145R | 0.886 |
| 17:43783230:A:C | N122T | 0.878 |
| 17:43783300:G:C | W145C | 0.873 |
| 17:43783300:G:T | W145C | 0.873 |
| 17:43783230:A:T | N122I | 0.869 |
| 17:43781832:T:G | I85S | 0.867 |
| 17:43781869:C:G | C97W | 0.861 |
| 17:43783229:A:C | N122H | 0.861 |
| 17:43781867:T:C | C97R | 0.859 |
| 17:43783230:A:G | N122S | 0.858 |
| 17:43781864:G:C | D96H | 0.857 |
| 17:43781810:A:G | N78D | 0.853 |
dbSNP variants (sampled 300 via entrez): RS1000602014 (17:43778777 C>A,T), RS1000972813 (17:43778936 G>A,T), RS1001088813 (17:43779011 G>A,C,T), RS1001236686 (17:43778873 C>T), RS1001251253 (17:43784691 G>T), RS1001648136 (17:43781830 A>T), RS1001790932 (17:43779344 C>T), RS1002250814 (17:43780259 A>G), RS1002858277 (17:43787071 A>G), RS1002910075 (17:43786857 T>C), RS1002912329 (17:43783056 C>T), RS1003355694 (17:43782872 T>G), RS1003371397 (17:43781153 G>A,T), RS1004443983 (17:43780412 T>A,C), RS1004534527 (17:43785128 C>T)
Disease associations
OMIM: gene MIM:619866 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
14 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST008070_25 | HDL cholesterol levels | 2.000000e-10 |
| GCST008070_90 | HDL cholesterol levels | 9.000000e-09 |
| GCST008074_103 | Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) | 8.000000e-20 |
| GCST008074_48 | Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) | 5.000000e-21 |
| GCST008075_153 | HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) | 9.000000e-34 |
| GCST008075_18 | HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) | 7.000000e-31 |
| GCST008083_149 | Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) | 7.000000e-21 |
| GCST008083_85 | Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) | 1.000000e-22 |
| GCST008084_154 | HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) | 1.000000e-41 |
| GCST008084_30 | HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) | 3.000000e-36 |
| GCST008085_143 | HDL cholesterol levels in current drinkers | 4.000000e-12 |
| GCST008085_22 | HDL cholesterol levels in current drinkers | 2.000000e-13 |
| GCST008087_23 | Triglyceride levels in current drinkers | 2.000000e-08 |
| GCST008087_97 | Triglyceride levels in current drinkers | 2.000000e-07 |
EFO canonical traits (3, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004612 | high density lipoprotein cholesterol measurement |
| EFO:0004530 | triglyceride measurement |
| EFO:0004329 | alcohol drinking |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
8 total (human), top 8 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| bisphenol F | affects cotreatment, increases methylation | 1 |
| tebuconazole | decreases expression | 1 |
| Grape Seed Proanthocyanidins | affects cotreatment, increases expression | 1 |
| Fulvestrant | affects cotreatment, increases methylation | 1 |
| Catechin | affects cotreatment, increases expression | 1 |
| Lead | increases expression | 1 |
| Methotrexate | increases expression | 1 |
| Tretinoin | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.